Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

NIBAN2 decreases the amount of CYLD. 2 / 2

| 2

➶

reach

"The combined results identified that MEG3 suppressed melanoma cell proliferation and invasion by regulating the expression of CYLD mediated by sponging miR-499-5p."

29808164

➶

reach

"Overexpression of MEG3 dramatically decreased the level of miR-499-5p and promoted CYLD protein expression; however, downregulation of MEG3 distinctly increased the miR-499-5p expression and inhibited CYLD protein expression."

29808164

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...